الفهرس 
BUDD–CHIARI SYNDROME (BCS)Only 14 pages are availabe for public view
 |  | from | 282 |  |  |
| | | from | 282 | | |
Abstract
Budd-Chiari syndrome (BCS) is a clinical condition caused by hepatic venous outflow obstruction located anywhere from the small hepatic veins to the junction of the inferior vena cava and the right atrium, regardless of the cause of the obstruction.
Hepatic venous outflow obstruction causes centrilobular congestion and hepatocyte necrosis, which if not treated can lead to hepatic lobulation and cirrhosis.
Variceal gastrointestinal bleeding is one of the most common life-threatening complications of portal hypertension with significant morbidity and mortality. Variceal size is identified to be one of the most important factors responsible for first variceal hemorrhage.
Esophageal varices constituted the main source as well as the main independent predictor for bleeding unrelated to invasive therapy for BCS.
The aim beyond this study was to evaluate the portal hypertension index and liver vascular index as non-invasive predictors of varices in Egyptian patients with BCS. To fulfill such purpose, we studied the characteristics of 50 BCS patients (fulfilling the inclusion criteria) referred to the Budd-Chiari Study group (BCSG) and admitted to Tropical Medicine Department, Ain Shams University Hospital or attended the outpatient clinics from May 2019 to January 2022. Based upon findings of upper Gastro-intestinal endoscopy, Patients in this study were classified into Non variceal group and variceal group. The latter was subdivided into small and large variceal subgroups.